Successful treatment of persistent and severe SARS-CoV-2 infection in a high-risk chronic lymphocytic leukemia patient using Ronapreve&#8482; antibodies.

Seganfredo, Fernanda Braga; Dias, Ana Raquel; Santos, Pedro R; Rebelo, Marta; João, Cristina; Mendes, Dina; Carmo, Eduarda

Successful treatment of persistent and severe SARS-CoV-2 infection in a high-risk chronic lymphocytic leukemia patient using Ronapreve™ antibodies.

Seganfredo, Fernanda Braga; Dias, Ana Raquel; Santos, Pedro R; Rebelo, Marta; João, Cristina; Mendes, Dina; Carmo, Eduarda.

Afiliación

Seganfredo FB; Haematology Department Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG) Lisbon Portugal.
Dias AR; Haematology Department Hospital do Divino Espírito Santo de Ponta Delgada Ponta Delgada Portugal.
Santos PR; Intensive Care Unit Centro Hospitalar Lisboa Ocidental - Hospital Egas Moniz Lisbon Portugal.
Rebelo M; Intensive Care Unit Centro Hospitalar Lisboa Ocidental - Hospital Egas Moniz Lisbon Portugal.
João C; Haematology Department Fundação Champalimaud Lisbon Portugal.
Mendes D; Pharmaceutical Department Centro Hospitalar Lisboa Ocidental - Hospital Egas Moniz Lisbon Portugal.
Carmo E; Intensive Care Unit Centro Hospitalar Lisboa Ocidental - Hospital Egas Moniz Lisbon Portugal.

Clin Case Rep ; 10(11): e6548, 2022 Nov.

Article en En | MEDLINE | ID: mdl-36408087

Palabras clave

COVID19; Casirivimab and Imdevimab; haematooncological patients; immunity

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Clin Case Rep Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google